FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer

Axel Grothey, Daniel J. Sargent

Research output: Contribution to journalEditorial

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)3311-3313
Number of pages3
JournalJournal of Clinical Oncology
Volume23
Issue number15
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this